Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.41 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL360096 | 1.00 | SLC7A5 (0.48) | SLC7A5SLC1A3SLC1A2SLC1A1GLO1 | |
| SCHEMBL7093020 | 0.80 | TP53 (0.39) | SLC7A5ALDH1A1MAPTTP53 | |
| SCHEMBL4131336 | 0.78 | SLC7A5 (0.46) | SLC7A5SLC1A3SLC1A2SLC1A1GLO1 | |
| SCHEMBL342124 | 0.74 | — | — | |
| SCHEMBL2451003 | 0.74 | — | — | |
| SCHEMBL13772961 | 0.73 | SLC7A5 (0.48) | SLC7A5SLC1A3SLC1A2SLC1A1GLO1 | |
| SCHEMBL1130837 | 0.72 | — | — | |
| SCHEMBL10154407 | 0.70 | TP53 (0.38) | SLC7A5TP53 | |
| Valine SCHEMBL9321177 | 0.70 | SLC7A5 (0.83) | SLC7A5SLC1A3SLC1A2SLC1A1GLO1 | |
| SCHEMBL26235264 | 0.70 | SLC7A5 (0.40) | SLC7A5SLC1A3SLC1A2SLC1A1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240366738-A1 | MOLECULAR VACCINES FOR INFECTIOUS DISEASE | AGILENT TECHNOLOGIES INC (US) | 2024-11-07 | — | — | US | disclosed |
| US-11992518-B2 | Molecular vaccines for infectious disease | AGILENT TECHNOLOGIES, INC. (US) | 2024-05-28 | — | — | US | disclosed |
| US-20220304923-A1 | USE OF ORAL CHEW FOR MODULATING ORAL MICROBIOTA AND IMPROVING ORAL HEALTH | MARS, INCORPORATED (US) | 2022-09-29 | — | — | US | disclosed |
| US-20220304335-A1 | MODULATION OF ORAL MICROBIOTA | MARS, INCORPORATED (US) | 2022-09-29 | — | — | US | disclosed |
| EP-3979813-A1 | MODULATION OF ORAL MICROBIOTA | Mars Incorporated (US) | 2022-04-13 | — | — | EP | disclosed |
| CN-114126417-A | Use of oral chews to regulate oral microbiota and improve oral health | 马斯公司 | 2022-03-01 | — | — | CN | disclosed |
| CN-114040681-A | Modulation of oral microbiota | 马斯公司 | 2022-02-11 | — | — | CN | disclosed |
| WO-2020247958-A9 | MODULATION OF ORAL MICROBIOTA | MARS, INCORPORATED (US) | 2021-09-23 | — | — | WO | disclosed |
| US-10968269-B1 | MHC multimers in borrelia diagnostics and disease | AGILENT TECHNOLOGIES, INC. (US) | 2021-04-06 | — | — | US | disclosed |
| US-20210047383-A1 | MHC Multimers in Borrelia Diagnostics and Disease | DAKO DENMARK APS (DK) | 2021-02-18 | — | — | US | disclosed |
| WO-2010037402-A1 | MOLECULAR VACCINES FOR INFECTIOUS DISEASE | DAKO DENMARK A/S (DK) | 2010-04-08 | — | — | WO | disclosed |
| WO-2010037395-A2 | MHC MULTIMERS IN CANCER VACCINES AND IMMUNE MONITORING | DAKO DENMARK A/S (DK) | 2010-04-08 | — | — | WO | disclosed |
| WO-2009106073-A2 | MHC MULTIMERS IN BORRELIA DIAGNOSTICS AND DISEASE | DAKO DENMARK A/S (DK) | 2009-09-03 | — | — | WO | disclosed |
| US-20090140136-A1 | Method Of Analyzing Protein | NEC CORPORATION (JP) | 2009-06-04 | — | — | US | disclosed |
| EP-2043672-A2 | SELECTIVE CASPASE INHIBITORS | The Board of Trustees of The Leland Stanford Junior University (US) | 2009-04-08 | — | — | EP | disclosed |
| WO-2009039854-A2 | MHC MULTIMERS IN TUBERCULOSIS DIAGNOSTICS, VACCINE AND THERAPEUTICS | DAKO DENMARK A/S (DK) | 2009-04-02 | — | — | WO | disclosed |
| WO-2008008264-A2 | SELECTIVE CASPASE INHIBITORS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2008-01-17 | — | — | WO | disclosed |
| WO-2006127715-A1 | ANTIMICROBIAL PEPTIDES | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2006-11-30 | — | — | WO | disclosed |
| EP-1430307-A2 | A METHOD OF PROTEIN ANALYSIS | Oxford GlycoSciences (UK) Ltd, Attn: Mary Gadsden (GB) | 2004-06-23 | — | — | EP | disclosed |
| WO-2003027681-A2 | A METHOD OF PROTEIN ANALYSIS | OXFORD GLYCOSCIENCES (UK) LTD (GB) | 2003-04-03 | — | — | WO | disclosed |